Drawing for MEIKEFANBAO

USPTO serial 98735522

MEIKEFANBAO

Reviewed by CopyMark Law Group

Status 622
Filing date
—
Status date
Registration date
—
Examiner
—
Law office
—

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MEIKEFANBAO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Miticides; Anti-inflammatory sprays; Antifungal preparations; Bone paste for medical purposes; Calcium fortified candy for medical purposes; Dietary food supplements; Hemorrhoidal ointments; Herbal male enhancement capsules; Liquid nutritional supplement; Medicated make-up; Medicinal preparations for stimulating hair growth; Mentholated ointment for medical use; Multipurpose medicated antibiotic cream, analgesic balm and mentholated salve; Nutritional supplement for eliminating toxins from the intestinal tract; Nutritionally fortified beverages for medical purposes; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Sports cream for relief of pain; Therapeutic agents for weight control and appetite suppressionACTIVEAug 23, 2024

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 21, 2025NOTICE OF INCOMPLETE APPLICATION – EMAILED—
Nov 15, 2024CRAFAMENDMENT CORRESPONDENCE ENTERED—
Sep 5, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 5, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance